相关实验视频

Updated: Jan 11, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

针对HPV16 E6的类似药物化合物的结构导向发现,用于抗病毒疗法开发

Jingying Shang¹, Qifan Jiang², Ting Liu¹

¹Department of Heilongjiang University of Chinese Medicine, Harbin 150040, China.

Iranian journal of biotechnology

|November 19, 2025

概括

研究人员发现了针对人类乳头瘤病毒16型 (HPV16) E6上蛋白的新型小分子. 这些类似药物的化合物显示出作为HPV相关癌症的抗病毒剂的前景,需要进一步验证.

科学领域:

计算化学是一种计算化学.
药物发现药物发现
在瘤学瘤学.

背景情况:

人类乳头瘤病毒16型 (HPV16) E6上蛋白驱动子宫癌和其他癌症.
用小分子向HPV16 E6提供了一种新的抗病毒疗法策略.

研究的目的:

发现和描述HPV16E6.6的小分子抑制剂.
识别具有高亲和力,有利的类似药物的特性和抑制活性的化合物.

主要方法:

集成的分子动力学模拟和基于结构的虚拟选.
评估了结合稳定性,相互作用模式和在中ADMET的特性.
利用分子对接,MM-GBSA和MD模拟进行分析.

主要成果:

确定了9种与HPV16 E6 (CYS51) 稳定结合的化合物.
大多数候选药物的强烈理论结合亲和和和有利的药物动力学特征得到证实.
两种化合物表明了潜在的毒性问题.

结论:

开发了一个用于识别HPV16 E6抑制剂的计算框架.
确定了 HPV 相关疾病治疗的有前途的类似药物候选者.
建议进行实验验证,以确认治疗潜力.

关键词:

抗病毒剂是一种抗病毒剂.药物发现药物发现在HPV16 E6中使用.分子动力学分子动力学小分子抑制剂小分子抑制剂虚拟选是一个虚拟的选.

更多相关视频

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...